


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-19.19%
-25.72%
+9.03%
-5.38%
-4.47%
ORCL
Oracle
$136.48
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Outperform the market

Trading below its fair value
Technical Indicators

5+ Days Down
ORCL Price Performance
$198.52 (-31.25%)
$236.15 (-42.21%)
$302.14 (-54.83%)
$169.96 (-19.70%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a weak earnings

Has a weak balance sheet

Revenue increase YoY

Earnings decline YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow

Outperform the market

Trading below its fair value
![]()
ORCL Analysts opinion is positive but there was a setback from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
ORCL Street Sentiment is bullish but have mixed views on the near-term outlook
ORCL has Low risk level
Risks Indicators

Beta greater than 1.0

Investors losing confidence

Average key support and resistance price levels
Recent Upgrades and Downgrades
STRONG BUY
Date
Action
Rating
Firm
Feb 03, 2026
Reiterate
an Overweight
Barclays
Jan 25, 2026
Reiterate
Buy
Guggenheim
Jan 12, 2026
Upgrade
Buy
Goldman Sachs
Dec 17, 2025
Upgrade
Hold
Dec 12, 2025
Reiterate
Buy
Citigroup
MSFT
Microsoft
393.67
-4.95%
NOW
ServiceNow
102.63
-7.60%
CVLT
Commvault Systems In
81.34
-0.77%
QLYS
Qualys
127.81
-1.06%
GEN
Gen Digital Inc.
22.43
-2.18%
What is ORCL current stock price?
What are ORCL stock strengths?
What is ORCL Risk Level?
What is ORCL market cap and volume?
What is ORCL current Stock IQ?
Should I buy ORCL stock right now?
Is ORCL a Strong Buy right now?
What does a 'Strong Buy' rating mean for ORCL?
What does a 'Strong Sell' rating mean for ORCL?
What factors influence ORCL's Stock IQ?
Join over 5,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-19.19%
-25.72%
+9.03%
-5.38%
-4.47%
ORCL
Oracle
Current Price
$136.48
Runners Also Watch
MSFT
Microsoft
393.67
-4.95%
NOW
ServiceNow
102.63
-7.60%
CVLT
Commvault Systems In
81.34
-0.77%
QLYS
Qualys
127.81
-1.06%
GEN
Gen Digital Inc.
22.43
-2.18%

ORCL Price Performance
$198.52 (-31.25%)
$236.15 (-42.21%)
$302.14 (-54.83%)
$169.96 (-19.70%)
ORCL Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a weak earnings

Has a weak balance sheet

Revenue increase YoY

Earnings decline YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow

Outperform the market

Trading below its fair value
![]()
ORCL Analysts opinion is positive but there was a setback from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
ORCL Street Sentiment is bullish but have mixed views on the near-term outlook
ORCL has Low risk level
Risks Indicators

Beta greater than 1.0

Investors losing confidence

Average key support and resistance price levels
Overall Wall Street Rating
STRONG BUY
Feb 03, 2026
Reiterate
an Overweight
Barclays
Jan 25, 2026
Reiterate
Buy
Guggenheim
Jan 12, 2026
Upgrade
Buy
Goldman Sachs
Dec 17, 2025
Upgrade
Hold
Dec 12, 2025
Reiterate
Buy
Citigroup
Dec 12, 2025
Reiterate
Buy
Stifel
Dec 12, 2025
Reiterate
Buy
UBS
ORCL Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Outperform the market

Trading below its fair value
Technical Indicators

5+ Days Down
ORCL Latest Analysis
3 Reasons to Hold Oracle Stock Despite 43% Decline in 6 Months. ORCL is down 42% in six months but a $523 billion backlog rapid cloud growth and multi-cloud momentum offer reasons to hold despite execution worries.
Today
Comparative Study: Microsoft And Industry Competitors In Software Industry. In today'.s rapidly changing and fiercely competitive business landscape it is vital for investors and industry enthusiasts to carefully evaluate companies. In this article we will perform a comprehensive industry comparison evaluating Microsoft (NASDAQ:MSFT) against its key competitors in the Software industry. By analyzing important financial metrics market position and growth prospects we aim to provide valuable i
Today
Scotiabank Cuts Oracle (ORCL) Target to $220 Keeps Sector Outperform. Oracle Corporation (NYSE:ORCL) is one of the 10 Buzzing AI Stocks on Market Radar. On February 3 Scotiabank analyst Pat Colville lowered the price target on the stock $220 (from $260) maintaining a Sector Outperform rating. Despite some bottlenecks the firm has expressed its confidence in Oracles GPUaaS strength and capital access. The firm highlighted Oracles [….]
Today
Exploring The Competitive Space: Microsoft Versus Industry Peers In Software. In today'.s rapidly changing and highly competitive business world it is imperative for investors and industry observers to carefully assess companies before making investment choices. In this article we will undertake a comprehensive industry comparison evaluating Microsoft (NASDAQ:MSFT) vis-à-vis its key competitors in the Software industry. Through a detailed analysis of important financial indicators market sta
Wed Feb 4, 2026
Oracle Teams Up With Canadian Healthcare Organizations To Launch Clinical AI Pilot Project. ORCL) has teamed up with several Canadian healthcare organizations on Wednesday with administrative burdens for physicians.The integration of Oracle Health’.s AI technology is expected to automatically generate narrative-rich draft notes from clinical interactions allowing physicians to focus more on patient care rather than administrative tasks. This pilot project builds on the previous unification
Wed Feb 4, 2026
UBS Cuts Oracle (ORCL) Target but Sees Funding Clarity as a Catalyst.
Wed Feb 4, 2026
Relative Strength Alert For Oracle. The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks according to a proprietary formula designed to identify those stocks that combine two important characteristics &mdash. strong fundamentals and a valuation that looks inexpensive.
Tue Feb 3, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
ORCL Stock trends
ORCL Stock performance
ORCL Stock analysis
ORCL investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.